Connect with us

Cannabis

Global Unmanned Aircraft Systems Market Size Forecasted to Grow to USD 48.17 Billion by 2030, at 7.56% CAGR | Reimagining Aviation

Published

on

New York, NY, Aug. 19, 2023 (GLOBE NEWSWIRE) — Zion Market Research has published a new research report titled “Unmanned Aircraft Systems Market By Range (Beyond Line Of Sight, Extended Visual Line Of Sight, And Visual Line Of Sight), By System (Payload, Airframe, Software, Propulsion, And Avionics), By Technology (Semi Autonomous, Remotely Operated, And Fully Autonomous.),By Application(Consumer, Law & Government Enforcement, Commercial, And Military), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

“According to the latest research study, the demand of global Unmanned Aircraft Systems Market size & share in terms of revenue was valued at USD 26.89 billion in 2022 and it is expected to surpass around USD 48.17 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 7.56% during the forecast period 2023 to 2030.”

What are Unmanned Aircraft Systems? How big is the Unmanned Aircraft Systems Industry?

Unmanned Aircraft Systems (UAS), commonly known as drones, are spearheading a transformative era of technological advancement, showcasing remarkable capabilities and a multitude of applications. These unmanned aerial vehicles are catalyzing a paradigm shift across global industries, ushering in a plethora of possibilities across both commercial and non-commercial domains. UAS are reshaping our perception of and interaction with the world, spanning a spectrum of contexts from military operations to agriculture, environmental monitoring, and beyond.

The market for Unmanned Aircraft Systems (UAS) encompasses a diverse range of aircraft that operate devoid of onboard human pilots. These systems are either remotely controlled or autonomously programmed to execute a wide spectrum of functions, including data collection, surveillance, goods transportation, and disaster response. With pioneering breakthroughs in aircraft engineering, artificial intelligence, and sensor technology, Unmanned Aerial Systems (UAS) have transcended their initial military origins, finding utility in multifaceted industries that reap the benefits of their efficacy, precision, and adaptability.

The objective of this market introduction is to furnish an overview of the Unmanned Aircraft Systems market, delving into the myriad types of UAS, their significance in today’s swiftly evolving technological landscape, and the diverse industries they are poised to revolutionize. As we navigate the intricacies of this dynamic sector, we will uncover the innovative prowess of Unmanned Aerial Systems (UAS), their profound impact across various industries such as agriculture, environmental conservation, and infrastructure, and we will explore the forthcoming opportunities and challenges that mark the dawn of this unmanned flight era.

Report Overview:

The global unmanned aircraft systems market size was worth around USD 26.89 Billion in 2022 and is predicted to grow to around USD 48.17 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 7.56% between 2023 and 2030.

An unmanned aerial vehicle (UAV), also known as an unmanned aircraft system, is a small-scale, pilotless aircraft that is constrained in its abilities to perform and explore its desired capabilities by either distance or the utilizations or applications that require streamlined powers. These are used to lift and distribute modest administrations, small payloads, static cameras for videography and photography, as well as to carry out military missions and projects in general.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs – https://www.zionmarketresearch.com/sample/unmanned-aircraft-systems-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 214+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
  • Zion Market Research research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Global Unmanned Aircraft Systems Market: Growth Factors

An unmanned aerial vehicle (UAV), also known as an unmanned aircraft system, is a small-scale, pilotless aircraft that is constrained in its abilities to perform and explore its desired capabilities by either distance or the utilizations or applications that require streamlined powers. The enhanced capabilities of UAVs allow for the analysis of a large number of photos to deliver confidential, protected, and accurate data, which in turn contributes to increased decision-making capabilities in a variety of industries. The global market for unmanned aircraft systems is being further improved as a result of the growing reliance of businesses on accurate information resources and the analysis of data derived from the product. Because of advancements in computing technology, faster microprocessors, and more sophisticated cameras, customers are receiving consistent support as a result of new developments in both the equipment and the segments that serve them.

Through the use of aerial images and advanced computation, drones are able to create maps in real time with the assistance of live guides. As a consequence of this, a number of market participants are concentrating their efforts on integrating machine learning and artificial intelligence in order to study a substantial amount of data. This is because UAVs routinely capture a large number of aerial photos. A great number of companies are currently working on the development of programming tools that will automate site inspection using item ID and estimating methods.

Because of the numerous capabilities associated with the development of drone technology, there has been a noticeable increase in the demand for unmanned aerial vehicles (UAVs) in a variety of countries during the past few years. As a result of an increase in demand brought on by an increase in the frequency of border crossing and enemy trespassing, numerous nations have invested in the development and manufacture of unmanned aircraft system market. It is designed to carry out a variety of tasks, including knowledge, observation, and surveillance, across a number of distinct missions. The streamlined constructions are designed to be used for airstrikes at the place that has already been determined. Roughly fifty countries have each purchased and developed their own unique unmanned aerial vehicle (UAV) to better prepare for potential conflicts and fight against acts of terrorism in the future.

Massive infrastructure development projects require continuous information in order to understand the ground reality and anticipated issues in the future. The development industry is currently facing the rapidly increasing usage of UAVs in a variety of sizes. It is assisting a variety of designers and specialists in making more astute decisions for their respective businesses.

Business drones are being put to use in a variety of countries for the purposes of evaluating, planning, and testing various applications. Because of stringent government regulations regarding the utilisation of airspace, the company is having a hard time expanding its market share in a few countries. These regulations are in place to avoid any accidental injuries or health issues. In addition, there is a lack of air traffic management, which, in regard to the commercial flights of UAVs and restrictions in metropolitan areas, is expected to be a barrier to future development in the coming years.are used to lift and distribute tiny administrations, small payloads, static camera for filming and photography, and to carry out military operations and projects in addition to their other uses.

Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/prebook/su/unmanned-aircraft-systems-market

Report Scope

Report Attribute Details
Market Size in 2022 USD 26.89 billion
Projected Market Size in 2030 USD 48.17 billion
CAGR Growth Rate 7.56% CAGR
Base Year 2022
Forecast Years 2023-2030
Key Market Players Northrop Grumman, General Atomics, Boeing, Textron Inc., SZ DJI, 3D Robotics, Parrot, and Aeryon Labs.
Key Segment By Range, By System, By Technology, By Application, and By Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase Options Request customized purchase options to meet your research needs. Explore purchase options

Unmanned Aircraft Systems Market: Segmentation Analysis

The market for unmanned aircraft systems on a global scale can be broken down into several different categories: vertical, range, system, UAV type, technology, and geography. The market has been divided into three categories: beyond line of sight, extended visual line of sight, and visual line of sight, based on the range at which the products can be seen. The beyond line of sight (BLOS) category is expected to lead with the highest CAGR during the period covered by the forecast. The market is divided into the following categories: payload, airframe, software, propulsion, and avionics based on the system. The global market for unmanned aircraft systems can be broken down into three categories based on the level of autonomy provided by the aircraft: fully autonomous, remotely operated, and partially autonomous.

The global market for unmanned aircraft systems is segmented into the following four categories, based on the application they are used for: consumer, law and government enforcement, commercial, and military. It is anticipated that the business sector would experience significant growth in the years to come. This expansion can be attributed to the expanding use of unmanned aerial vehicles (UAVs) in a variety of commercial applications, including mapping, monitoring, remote sensing, and surveying.

According to the class, the global market for unmanned aerial vehicles (UAVs) is divided into four subcategories: small UAVs, strategic UAVs, tactical UAVs, and special-purpose UAVs. As a result of increased demand for drones in the military sector and reconnaissance applications, the market for small unmanned aerial vehicles (UAVs) is expected to develop at the greatest compound annual growth rate (CAGR) over the forecast period. Because of its widespread applications in logistics and transportation, agriculture, wildlife surveying, firefighting, photography, and law enforcement, there has been an increase in the demand for this sector from the commercial sector. This increase has contributed to the rise in demand for this segment.

Market Opportunities

  • Rising Demand for Delivery and Logistics
  • Expansion in Defense and Military Applications
  • Remote Sensing and Mapping Opportunities
  • Emergence of Urban Air Mobility (UAM)

The global Unmanned Aircraft Systems market is segmented as follows:

By Range

  • Beyond Line Of Sight 
  • Extended Visual Line Of Sight
  • Visual Line Of Sight 

By System

  • Payload
  • Airframe
  • Software
  • Propulsion
  • Avionics

By Technology

  • Semi Autonomous
  • Remotely Operated
  • Fully Autonomous

By Application

  • Consumer
  • Law & Government Enforcement
  • Commercial
  • Military

Browse the full “Unmanned Aircraft Systems Market By Range (Beyond Line Of Sight, Extended Visual Line Of Sight, And Visual Line Of Sight), By System (Payload, Airframe, Software, Propulsion, And Avionics), By Technology (Semi Autonomous, Remotely Operated, And Fully Autonomous.),By Application(Consumer, Law & Government Enforcement, Commercial, And Military), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030″ Report At https://www.zionmarketresearch.com/report/unmanned-aircraft-systems-market

Competitive Landscape

Some of the main competitors dominating the global Unmanned Aircraft Systems market include – 

  • Northrop Grumman 
  • General Atomics
  • Boeing
  • Textron Inc.
  • SZ DJI
  • 3D Robotics 
  • Parrot
  • Aeryon Labs

 Key Insights from Primary Research:

  • According to the analysis shared by our research forecaster, the Unmanned Aircraft Systems market is likely to expand at a CAGR of around 7.56% during the forecast period (2023-2030).            
  • In terms of revenue, the Unmanned Aircraft Systems market size was valued at around US$ 26.89 billion in 2022 and is projected to reach US$ 48.17 billion by 2030.
  • The global unmanned aircraft systems (UAS) market size has been analyzed across four major regions.
  • Porter’s five force analysis helps to analyze the potential of buyers & suppliers and the competitive scenario of the unmanned aircraft systems (UAS) for strategy building.
  • The report outlines the current market trends and future scenario of the market size to understand the prevailing opportunities and potential investment pockets.
  • Major countries in each region have been mapped according to their individual revenue contribution to the regional market.
  • The key drivers, restraints, opportunities, and market trends along with their detailed impact analysis are elucidated in the study.
  • The market analysis covers in-depth information of major industry participants.

Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/unmanned-aircraft-systems-market

Key questions answered in this report:

  • What is the market size and growth rate forecast for Unmanned Aircraft Systems industry?
  • What are the main driving factors propelling the Unmanned Aircraft Systems Market forward?
  • What are the leading companies in the Unmanned Aircraft Systems Industry?
  • What segments does the Unmanned Aircraft Systems Market cover?
  • How can I receive a free copy of the Unmanned Aircraft Systems Market sample report and company profiles?

Key Offerings:

  • Market Size & Forecast by Revenue | 2023−2030
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis By Range, By System, By Technology, By Application, and By Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements – https://www.zionmarketresearch.com/custom/5985

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

On the basis of geography, the Middle East & Africa and Europe region led the marketin pastyears and are likely to maintain the lead during the forecast period as well. In addition, Asia Pacific is another region in the global unmanned aircraft systems market depicting a promising growth in the upcoming years.

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Unmanned Aircraft Systems (UAS) market Importance and Applications

The market for unmanned aircraft systems (also known as UAS) is extremely important since its applications may be found in a wide variety of different industries. The use of unmanned aerial systems, more generally known as drones, has expanded far beyond its initial application in the military and is now ingrained in both the business and non-commercial spheres. Because of their adaptability, effectiveness, and low cost, they are increasingly being utilised for a diverse range of applications as a result. The following are some of the most important applications that illustrate why the UAS market is so important:

Surveillance and Reconnaissance: In the context of military and security activities, UAS are put to wide use for the purposes of surveillance and reconnaissance. Real-time airborne imagery and data collecting are provided by them, which contributes to improved situational awareness without putting people in danger.

Agriculture: Monitoring crop health, identifying insect infestations, and determining the optimal amount of irrigation are all examples of precision agriculture tasks that can be assisted by drones fitted with sophisticated sensors and cameras. This technique, which is driven by data, increases yields while also lowering the amount of resource waste.

Environmental Monitoring: Monitoring environmental changes like deforestation, watching wildlife, and measuring levels of pollution are all important jobs for unmanned aerial systems (UAS). They supply researchers with important data that can be used for evaluating the effects of climate change and aiding in conservation efforts.

Search and Rescue: UAS are helpful to search and rescue activities because they can cover huge areas fast and access spots that are difficult to access. During times of crisis, thermal cameras and sensors can help locate survivors or people who have gone missing.

Infrastructure Inspection: Inspections of essential pieces of infrastructure, such as bridges, electrical lines, and pipelines, can be carried out by drones. They are able to access locations that are impossible or unsafe for humans to enter, which allows them to identify maintenance needs and reduce downtime.

Surveying and Mapping: The production of high-resolution aerial maps and 3D models for use in urban planning, building, and land surveying can all be accomplished with the help of UAS. This technology not only improves accuracy but also cuts expenses and speeds up deadlines for projects.

Delivery and Logistics: The introduction of the idea of drone delivery has completely changed the logistics sector. Packages, medical supplies, and even food can be rapidly and efficiently delivered to remote or disaster-stricken areas by using unmanned aerial systems (UAS).

Media and Entertainment: Aerial photography and videography can be accomplished with the use of drones, which can capture magnificent images for use in movies, documentaries, news reports, and marketing campaigns.

Scientific Research: Researchers use UAS to collect data in remote and challenging environments, such as glaciers, volcanoes, and oceans. They contribute to scientific discoveries and improve our understanding of natural phenomena.

Surveillance and Security: In addition to their use in the military, unmanned aerial systems (UAS) are put to work in the fields of border patrol, event security, and crowd surveillance. These applications help improve public safety and awareness of the surrounding environment.

Emergency Response: During times of natural disaster, unmanned aerial systems (UAS) provide assistance to first responders by assessing the damage, locating survivors, and giving information that is essential for effective disaster management.

The vast number of possible applications demonstrates the enormous potential of the UAS market to revolutionise a variety of different industries and find solutions to difficult problems. The unmanned aerial systems (UAS) market is positioned for continuing growth and innovation across these many different areas as technology continues to improve at a rapid pace and regulations become more streamlined.

To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/unmanned-aircraft-systems-market

Browse Other Related Research Reports from Zion Market Research:

Physiotherapy Devices Market By Type (Hydrotherapy, Electrotherapy, Continuous Passive Motion Units, Multi-Exercise Therapy Unit, Heat Therapy, Ultrasound, And Other Equipment Types), By Application (Cardiovascular & Pulmonary, Neurological, Musculoskeletal, And Other Applications), By End-User (Hospitals, Rehabilitation Centers/Clinics, And Homes) And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/physiotherapy-devices-market

Plastic Straps Market By Type (Polyester Straps, Polypropylene Straps, Nylon Straps, And Others), By End-Use (Steel, Cotton, Paper, Fiber, Bricks & Tiles, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/plastic-straps-market

Household And DIY Hand Tools Market By Type (General Purpose Tools, Metal Cutting Tools, Layout & Measuring Tools, Taps & Dies), By Application (Household Appliances, Entertainment & Consumer Electronics, IT & Telecommunications, Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/household-and-diy-hand-tools-market

Cannabis Testing Market By Technology (Chromatography And Spectroscopy), By Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, And Mycotoxin Testing), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/cannabis-testing-market

Medical Marijuana Market By Type (Flowers, Concentrates, Edibles And Others), By Application (Chronic Pain, Mental Disorders, Cancer, And Others), By End User (Pharmaceutical And Research & Development Centers), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/medical-marijuana-market

Medical Disposables Market By Type (Glucose Monitoring Strips, Blood Collection Consumables, Diagnostic Catheters, Dialysis Consumables, Radiology Consumables, Infusion Products, Smart Syringes, Prefilled Syringes, Intubation & Ventilation Supplies, Hypodermic Products, Sterilization Consumables, Nonwoven Medical Supplies, Incontinence Products, Surgical Nonwoven Products, Wound Care Consumables, Infection Management Products, Exudate Management Products, And NPWT Devices), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/medical-disposables-market

Elevators And Escalators Market By Type (Elevators, Escalators, Moving Walkways), By Service (New Installation, Maintenance & Repair, And Modernization), By Elevator Technology (Traction, Machine-Room-Less, & Hydraulic), By End-Use Industry (Residential, Commercial, Institutional, Infrastructure, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/elevators-and-escalators-market

Cognitive And Memory Enhancer Drugs Market By Drug Type (Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, And Others), By Application (Disease Treatment, Academic Performance, Athletic Performance, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/cognitive-and-memory-enhancer-drugs-market

End Cartoning Machine Market By Product Type (Less Than 70 CPM, 70 CPM To 150 CPM, 150 CPM To 400 CPM, And More Than 400 CPM), By Orientation (Horizontal And Vertical), By Dimensions (Less Than 200 CC, 200 CC To 1,000 CC, 1,000 CC To 5,000 CC, 5,000 CC To 10,000 CC, And More Than 10,000 CC), By End-Use (Food & Beverage, Personal Care, Healthcare, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/end-cartoning-machine-market

Blood Glucose Monitoring System Market By Product (Self-Monitoring And Continuous Glucose Monitoring Devices), By Testing Site (Fingertip Testing And Alternate Site Testing), By Indication (Type-I Diabetes, Type-II Diabetes, And Others), By End-User (Hospitals, Clinics, And Homecare), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/blood-glucose-monitoring-system-market

Peptide Therapeutics Market By Route Of Administration (Parenteral, Oral, And Others), By Type (Innovative And Generic), By Type Of Manufacturers (In-House And Outsourced), By Type Of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, And Others), By Technology (Liquid Phase, Solid Phase, And Hybrid Phase), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/peptide-therapeutics-market

Cardiac Holter Monitor Market By Type (1-Channel, 2-Channel, 3-Channel, 12-Channel, And Others), By Component (Holter Monitoring Devices, Holter Analysis System & Software, And Event Monitoring Devices), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), Homecare, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/cardiac-holter-monitor-market

Encapsulated Flavors And Fragrances Market By Product (Flavor Blends, Fragrance Blends, Essential Oils & Natural Extracts, Aroma Chemicals), By Technology (Physical Process, Chemical & Physicochemical Process), By Encapsulation Process (Micro Encapsulation, Nano Encapsulation, Hybrid Technology, Macro Encapsulation), By End-Use (Food & Beverages And Toiletries & Cleaners), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/encapsulated-flavors-fragrances-market

GPON Equipment Market By Equipment Type (Optical Line Terminal And Optical Network Terminal), By End-Use Industry (Hospitals, Residential, IT & Telecom, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/gpon-equipment-market

Blood Transfusion Diagnostics Market By Product Type (Instruments, Kits & Reagents), By Application (Blood Grouping, Molecular Disease Screening), By End-User (Hospitals, Diagnostic Laboratories, Blood Banks), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/blood-transfusion-diagnostics-market

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch

Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/

Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 7768 006 007

Web: https://www.zionmarketresearch.com/

Blog: https://zmrblog.com/

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Email Directly Here with Detail Information: [email protected]

Cannabis

Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0

Published

on

Continue Reading

Cannabis

IM Cannabis Reports First Quarter Financial Results

Published

on

im-cannabis-reports-first-quarter-financial-results

IMC prepares for accelerated growth after legalization in Germany and recovers from the impact of the Israel-Hamas war.

TORONTO and GLIL YAM, Israel, May 8, 2024 /PRNewswire/ — IM Cannabis Corp. (the “Company” or “IMC“) (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2023, unless otherwise stated.

Q1 2024 Financial Highlights

  • 13% Revenue increase vs. Q4 2023 of $12.1M vs. $10.7M and 4% decrease vs. Q1 2023 of $12.5M

 

  • 125% Gross profit increase vs. Q4 2023 of $1.8M vs. $0.8 and 39% Gross profit decrease vs. Q1 2023 of $2.9M

 

  • 29% decrease in operating expenses vs. Q1 2023 excluding the one-time Oranim revoke related losses of $4.6M vs. $6.5M and 14% increase including Oranim

 

  • 12% increase of Non-IFRS Adjusted EBITDA loss to $2.1M

Operational Highlights

The Company intends to complete a non-brokered private placement (the “Offering“) of secured convertible debentures of the Company (each, a “Debenture“) for aggregate proceeds of up to C$2,500,000. The Debentures will mature on the date that is 12 months from the date of issuance and will not incur interest except in the event of default. The Debentures are being issued to holders of short term loans and obligations owed by the Company or its wholly owned subsidiaries. The principal of the Debenture may be converted into common shares in the Company (each, a “Share“) at a conversion price of $1.08 per Share.

Management Commentary 

“With the April 1st cannabis legalization in Germany, we are augmenting our focus and resources on the German market, where we expect to see the biggest growth potential, and the best return on investment. While it is still too early to make any predictions, our sales in Germany almost doubled during the month of April,” said Oren Shuster, Chief Executive Officer of IMC. “Looking back on the first month post legalization in Germany, I see that we have the infrastructure and the supply agreements in place to continue delivering the accelerated growth we have already seen in April. We will also ensure that we have the necessary resources in place for success.”   

“In 2023 we completely restructured, becoming a very lean and agile company, leaning into active cost management. This process is reflected in the numbers, our G&A decreased 27% vs Q1 2023” said Uri Birenberg, Chief Financial Officer of IMC. “While our results have recovered from the impact of the Israel-Hamas war, our revenue was still effected by both an unfavorable exchange rate, as well as price reductions to sell off inventory.”

Q1 2024 Conference Call 

The Company will host a Zoom web conference call today at 9:00 a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.

Q1 2024 Financial Results

  • Revenues for the first quarter of 2024 were $12.1 million compared to $12.5 million in the first quarter of 2023, a decrease of 3%. The decrease is mainly due an exchange rate effect of about $0.2 million and decrease in avg. price per sale due to increased competition.

 

  • Gross profit for the first quarter of 2024 was $1.8 million, compared to $2.9 million in Q1 2024, a decrease of 39%. The downside is attributed mainly to the slow-moving stock that was moved out at a lower price and an exchange rate difference totaling $0.4 million and $0.64 million cost of sales loss due to an inventory erase of the slow-moving stock. Company fair value adjustment was $0 and $0.4 million for the Q1 2024 and Q1 2023 respectively.

 

  • Total Dried Flower sold in Q1 2024 was approximately 1,873 kg with an average selling price of $5.68 per gram, compared to approximately 1,842kg in Q1 2023, with an average selling price of $6.59 per gram. This difference is mainly due to increased competition within the retail segment, and mid-range stock discounts to move out slow moving stock.

 

  • Total operating expenses in Q1 2024 were $7.4 million compared to $6.5 million in Q1 2023. The increase is due to the other operating expenses related to Oranim Deal revoke, with an expected losses of $2.8 million. Adjusting for this one-time losses, Q1 2024 operating expenses were $4.6 million compared to $6.5 million in Q1 2023, a decrease of 29%.

 

  • G&A Expenses in Q1 2024 were $2.3 million, compared to $3.2 million in Q1 2023, a decrease of 28%. The decrease in the G&A expense is attributable mainly to salaries and professional services of $0.64 million.

 

  • Selling and Marketing Expenses in Q1 2024 were $2.3 million, compared to $2.8 million in Q1 2023, a decrease of 18% mainly due to a decrease in Salaries and professional services of $0.5 million.

 

  • Net Loss from continuing operations in Q1 2024 was $6.0 million, compared to $0.9 million in Q12023.

 

  • Basic and diluted Loss per Share in Q1 2024 was $0.42, compared to a loss of $0.05 per Share in Q1 2023.

 

  • Non-IFRS Adjusted EBITDA loss in Q1 2024 was $2.1 million, compared to an Adjusted EBITDA loss of $1.9 million in Q1 2023 an increase of 10%.

 

  • Cash and Cash Equivalents as of March 31, 2024, were $1.0 million compared to $1.8 million in December 31, 2023.

 

  • Total assets as of March 31, 2024, were $41.1 million, compared to $48.8 million in December 31, 2023, a decrease of 16%. The decrease is mainly attributed to the goodwill reduction due to Oranim agreement cancelation of about $2.8M, a reduction in Inventory of $2.1 million, reduction of Cash and cash equivalents of $0.8M and reduction in Trade payables of $1.2 million.

 

  • Total Liabilities as of March 31, 2024, were $32.8 million, compared to $35.1 in December 31, 2023, a decrease of about 7%. The decrease was mainly due to the reduction in other accounts payables and accrued expenses of $1.8 million and reduction in the PUT option liability of $0.7 million.

 

The Company’s financial statements as of March 31, 2024 includes a note regarding the Company’s ability to continue as a going concern. The Company’s Q1 2024 financial results do not include any adjustments relating to the recoverability and classification of assets or liabilities that might be necessary should the Company be unable to continue as a going concern. For more information, please refer to the “Liquidity and Capital Resources” and “Risk Factors” sections in the Company’s management’s discussion and analysis for the quarter ended March 31, 2024.

Non-IFRS Measures

This press release makes reference to “Gross Margin” and “Adjusted EBITDA”, which are financial measures that are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. These measures are provided as complementary information to the Company’s IFRS measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these measures should neither be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS.

For an explanation of how management defines Gross Margin and Adjusted EBITDA, see the Company’s management’s discussion and analysis for the period ended March 31, 2024, available under the Company’s SEDAR+ profile at www.sedarplus.ca on EDGAR at www.sec.gov/edgar.
We reconcile these non-IFRS financial measures to the most comparable IFRS measures as set out below.

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Canadian Dollars in thousands

March 31,
2024

December 31,
2023

Note

(Unaudited)

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$           1,048

$           1,813

Trade receivables

6,506

7,651

Advances to suppliers

780

936

Other accounts receivable

3,732

3,889

Inventories

3

7,901

9,976

19,967

24,265

NON-CURRENT ASSETS:

Property, plant and equipment, net

4,939

5,058

Investments in affiliates

2,078

2,285

Right-of-use assets, net

1,243

1,307

Intangible assets, net

5,440

5,803

Goodwill

7,442

10,095

21,142

24,548

Total assets

$          41,109

$          48,813

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Canadian Dollars in thousands

March 31,
2024

December 31,
2023

Note

(Unaudited)

LIABILITIES AND EQUITY

CURRENT LIABILITIES:

 

Trade payables

$      9,511

$      9,223

Bank loans and credit facilities

11,941

12,119

Other accounts payable and accrued expenses

4,440

6,218

Accrued purchase consideration liabilities

2,165

2,097

PUT Option liability

1,967

2,697

Current maturities of operating lease liabilities

461

454

30,485

32,808

NON-CURRENT LIABILITIES:

 

Warrants measured at fair value

4

137

38

Operating lease liabilities

744

815

Long-term loans

401

394

Employee benefit liabilities, net

96

95

Deferred tax liability, net

902

963

2,280

2,305

Total liabilities

32,765

35,113

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:

5

Share capital and premium

253,887

253,882

Translation reserve

1,399

95

Reserve from share-based payment transactions

9,664

9,637

Accumulated deficit

(255,431)

(249,145)

Total equity attributable to equity holders of the Company

9,519

14,469

 Non-controlling interests

(1,175)

(769)

Total equity

8,344

13,700

Total liabilities and equity

$  41,109

$     48,813

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME (UNAUDITED)

Canadian Dollars in thousands, except per share data

Three months ended

March 31,

Note

2024

2023 (*)

Revenues

$      12,063

$      12,529

Cost of revenues

10,274

9,286

Gross profit before fair value adjustments

1,789

3,243

Fair value adjustments:

Realized fair value adjustments on inventory sold in the period

(10)

(339)

Total fair value adjustments

(10)

(339)

Gross profit

1,779

2,904

General and administrative expenses

2,332

3,175

Selling and marketing expenses

2,292

2,805

Restructuring expenses

283

Share-based compensation

32

258

Other operating expenses

9

2,753

Total operating expenses

7,409

6,521

Operating loss

5,630

3,617

Finance income

4

(14)

3,530

Finance expense

(487)

(795)

Finance income, net

(501)

2,735

Gain (loss) before income taxes

(6,131)

(882)

Income tax benefit

(111)

(16)

Net )loss( gain

(6,020)

(866)

Other comprehensive income that will not be reclassified to profit or loss in
 subsequent periods:

Total other comprehensive income that will not be reclassified to profit or loss
 in subsequent periods

67

36

Exchange differences on translation to presentation currency

1,330

(562)

Total other comprehensive income (loss) that will not be reclassified to profit
 or loss in subsequent periods

1,397

(526)

Other comprehensive income that will be reclassified to profit or loss in
 subsequent periods:

Adjustments arising from translating financial statements of foreign operation

(35)

155

Total other comprehensive income (loss) that will be reclassified to profit or loss
 in subsequent periods

(35)

155

Total other comprehensive income (loss)

1,362

(371)

Total comprehensive loss

$       (4,658)

$       (1,237)

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME (UNAUDITED)

Canadian Dollars in thousands, except per share data

Three months ended

March 31,

Note

2024

2023 (*)

Net income (loss) attributable to:

Equity holders of the Company

(5,623)

(600)

Non-controlling interests

(397)

(266)

$       (6,020)

$           (866)

Total comprehensive income (loss) attributable to:

Equity holders of the Company 

(4,252)

(959)

Non-controlling interests 

(406)

(278)

$       (4,658)

$       (1,237)

Net income (loss) per share attributable to equity holders of the Company

7

Basic and diluted (loss) gain per share (in CAD)

$           (0.42)

$           (0.05)

Earnings (loss) per share attributable to equity holders of the Company
 from continuing operations:

Basic and diluted (loss) gain per share (in CAD)

$         (0.42)

$          (0.05)

(*) See note 1 regarding figures disclosure.

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

Canadian Dollars in thousands

Three months ended

March 31,

2024

2023 (*)

Cash provided by operating activities:

Net income (loss) for the period

$    (6,020)

$          43

Adjustments for non-cash items:

Fair value adjustment on sale of inventory

10

339

Fair value adjustment on Warrants, investments and accounts receivable

100

(3,636)

Depreciation of property, plant and equipment

147

174

Amortization of intangible assets

452

456

Depreciation of right-of-use assets

118

179

Impairment of goodwill

2,753

Finance expenses, net

401

635

Deferred tax liability, net

(69)

(150)

Share-based payment

32

258

Restructuring expense

283

3,944

(1,462)

Changes in working capital:

Decrease (increase) in trade receivables

1,332

1,937

Decrease (increase) in other accounts receivable and advances to suppliers

159

(940)

Decrease (increase) in inventories, net of fair value adjustments

2,159

90

Decrease (increase) in trade payables

663

(6,021)

Changes in employee benefit liabilities, net

(22)

Increase in other accounts payable and accrued expenses

(2,745)

(14)

1,568

(4,970)

Taxes (paid) received

(121)

328

Net cash used in operating activities

(629)

(6,061)

Cash flows from investing activities:

Purchase of property, plant and equipment

(2)

(411)

Payment of purchase consideration

(56)

Net cash used in investing activities

$            (2)

$        (467)

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

Canadian Dollars in thousands

Three months ended

March 31,

2024

2023

Cash flow from financing activities:

   Proceeds from issuance of share capital, net of issuance costs

176

825

   Proceeds from issuance of warrants

(176)

7,027

   Repayment of lease liability

(118)

(175)

   Interest paid – lease liability

(15)

(18)

   Receipt (repayment) of bank loan and credit facilities

(2,856)

(1,046)

   Cash paid for interest

(444)

(56)

   Proceeds from discounted checks

2,581

Net cash (used in) provided by financing activities

(852)

6,557

Effect of foreign exchange on cash and cash equivalents

718

(1,059)

Decrease in cash and cash equivalents

(765)

(1,030)

Cash and cash equivalents at beginning of the period

1,813

2,449

Cash and cash equivalents at end of the period

$      1,048

$     1,419

Supplemental disclosure of non-cash activities:

Right-of-use asset recognized with corresponding lease liability

$           40

$          49

Issuance of shares in payment of debt settlement to a non-independent director of the company

$              –

$        222

(*) See note 1 regarding Figures disclosure.

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company also  operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries. The Company has exited operations in Canada and considers these operations as discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, “forward-looking statements“). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to: the impact of the Israel-Hamas war on the Company, including its operations and the medical cannabis industry in Israel; the timing and impact of the legalization of medicinal cannabis in Germany, including, the Company having it “all in house”; the Company being positioned to take advantage of the legalization; the Company’s growth in 2024; the market growth for medicinal cannabis in Germany;  the stated benefits of the Company’s EU-GMP processing facility and an EU-GDP logistics center; the Company to host a teleconference meeting as stated; and the Company’s stated goals, scope, and nature of operations in Germany, Israel, and other jurisdictions the Company may operate.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the Company’s ability to focus and resources to achieve sustainable and profitable growth in its highest value markets; the Company’s ability to mitigate the impact of the Israel-Hamas war on the Company; the Company’s ability to take advantage of the legalization of medicinal cannabis in Germany; the Company’s ability to host a teleconference meeting as stated; and the Company’s ability to carry out its stated goals, scope, and nature of operations in Germany, Israel, and other jurisdictions the Company may operate.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and its subsidiaries (collectively, the “Group“) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the Israel-Hamas war on the Company, its operations and the medical cannabis industry in Israel; risks associated with the Company focusing on the Israel and Germany markets; the inability of the Company to achieve sustainable profitability and/or increase shareholder value; the inability of the Company to actively manage costs and/or improve margins; the inability of the company to grow and/or maintain sales; the inability of the Company to meet its goals and/or strategic plans; the inability of the Company to reduce costs and/or maintain revenues; the Company’s inability to take advantage of the legalization of medicinal cannabis in Germany; and the Company’s inability to host a teleconference meeting as stated.

Please see the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report dated March 28, 2024, which is available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contact: 

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/im-cannabis-reports-first-quarter-financial-results-302139688.html

Continue Reading

Cannabis

Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania